Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication

Neurology

Volumn 38, Issue 4, 1988, Pages 550-553

  Bertolucci, P H F ^a  

^a Eacola Pauliata de Medicina ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; BIPERIDEN; CARBIDOPA PLUS LEVODOPA; LEVODOPA; MANEB; MANGANESE;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HUMAN; MALE; MANEB; MANGANESE; MIDDLE AGE; MOVEMENT DISORDERS; OCCUPATIONAL DISEASES; SUPPORT, NON-U.S. GOV'T; THIOCARBAMATES;

EID: 0023882918     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.4.550     Document Type: Article

References (32)

1. Peñalver R. Manganese poisoning: the 1954 Ramazzini oration. Ind Med Surg 1955;24:1–7.
2. Abd-El-Nabi S, Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatry 1965;28:282–288.
3. Barbeau A, Inoué N, Cloutier T. Role of manganese in dystonia. Adv Neurol 1976;14:339–352.
4. Mena I. Manganese, chap 7. In: Waldrom HA, ed. Metals in the environment. London: Academic Press, 1980:199–219.
5. Bencko V, Cikrt M. Manganese: a review of occupational and environmental toxicology. J Hyg Epidemiol Microbiol Immunol 1984;28:139–148.
6. Tanaka S, Lieben J. Manganese poisoning and exposure in Pennsylvania. Arch Environ Health 1969;19:674–684.
7. Cooper WC. The health implications of increased manganese in the environment resulting from the combustion of fuel additives: a review of the literature. J Toxicol Environ Health 1984;14:23–46.
8. World Health Organization (WHO). Environmental health criteria 17: manganese. Geneva, 1981:1–110.
9. Casamajor L. An unusual form of mineral poisoning affecting the nervous system: manganese. JAMA 1913;69:646–649.
10. Mena I, Marin O, Fuenzalida S, Cotzias GC. Chronic manganese poisoning: clinical picture and manganese turnover. Neurology 1967;17:128–136.
11. Whitlock Jr. CM, Amuso SJ, Bittenbender JB. Chronic neurological disease in two manganese steel workers. Am Ind Hyg Assoc J 1966;27:454–459.
12. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59–64.
13. Saric M, Markicevic A, Hrustic O. Occupational exposure to manganese. Br J Ind Med 1977;34:114–118.
14. Mena I, Horiuchi K, Lopez G. Factors enhancing entrance of manganese into the brain: iron deficiency and age. J Nucl Med 1974;15:516.
15. Chandra SV, Shukla GS. Role of iron deficiency in inducing susceptibility to manganese toxicity. Arch Toxicol 1976;35:319–323.
16. Horiuchi K, Horiguchi S, Shinagawa K, Utsunomia T, Tsuyama Y. On the significance of manganese contents in the whole blood and urine of manganese handlers. Osaka City Med J 1970;16:29–37.
17. Cotzias GC, Horiuchi K, Fuenzalida S, Mena I. Chronic manganese poisoning: clearance of tissue concentrations with persistence of neurological picture. Neurology 1968;18:378–382.
18. Chernoff N, Kavlock RJ, Rogers EH, Carver BD, Murray S. Perinatal toxicity of maneb, ethylenethiourea and ethylenebis-dithiocyanate sulfide in rodents. J Toxicol Environ Health 1979;5:821–834.
19. Vermes I, Toth EK, Telegdy G. Effect of drugs on brain neuro-transmitters and pituitary-testicular function of male rats. Horm Res 1970;10:222–232.
20. Corsini GU, Pintus S, Chiue CG, Weiss JF, Kopin IJ. 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur J Pharmacol 1985;119:127–128.
21. Israeli R, Sculsky M, Tiberin P. Acute central nervous system changes due to intoxication by Manzidan (a combined dithiocar-bamate of maneb and zineb). Arch Toxicol (Suppl) 1983;6:238–243.
22. Cotzias GC, Papavasiliou PS, Ginos J, Seck A, Düby S. Metabolic modification of Parkinson’s disease and of chronic manganese poisoning. Annu Rev Med 1971;22:305–326.
23. Cotzias GC, Miller ST, Papavasiliou PS, Tang LC. Interactions between manganese and brain dopamine. Med Clin North Am 1976;60:729–738.
24. Donaldson J, McCregor D, LaBella F. Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Can J Physiol Pharmacol 1982;60:1398–1405.
25. Lydén A, Larsson BS, Lindquist NG. Melanin affinity of manganese. Acta Pharmacol Toxicol (Copenh) 1984;55:133–138.
26. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson’s disease in Saskatchewan—environmental considerations for etiology. Can J Neurol Sci 1986;13:312–316.
27. Barbeau A, Roy M, Bernier G, Campanella G, Paris S. Ecogenetics of Parkinson’s disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 1987;14:36–41.
28. Bocchetta A, Corsini GU. Parkinson’s disease and pesticides. Lancet 1986;2:1163.
29. Calne DB, Langston JW. Aetiology of Parkinson’s disease. Lancet 1983;2:1457–1459.
30. Barbeau A, Roy M, Paris S, Cloutier T, Plasse L, Poirier J. Ecogenetics of Parkinson’s disease: 4-hydroxylation of debriso-quine. Lancet 1985;2:1213–1216.
31. Snyder SH, D’Amato RJ. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson’s disease: the 1985 George C. Cotzias lecture. Neurology 1986;36:250–258.
32. López-Alemany M. Parkinsonism as a late toxic effect of di-hydropyridines? Lancet 1986;1:737.